Related Experiment Video
Updated: Sep 28, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
Congenital tuberculosis and management of exposures in a neonatal intensive care unit
Brent W Laartz1, Hugo J Narvarte, Douglas Holt
1Division of Infectious Diseases, University of South Florida, Tampa General Healthcare, 33601-1289, USA.
Insights
Congenital tuberculosis is rare but requires prompt diagnosis and careful follow-up of exposed infants in the neonatal intensive care unit (NICU). Management included isoniazid prophylaxis and monitoring, showing no new infections in exposed neonates.
Area of Science:
- Neonatal Medicine
- Infectious Diseases
- Public Health
Background:
- Congenital tuberculosis is a rare but serious condition in newborns.
- Early diagnosis and treatment are crucial for successful outcomes.
- Managing potential exposures in a neonatal intensive care unit (NICU) setting is critical.
Observation:
- A case of congenital tuberculosis was diagnosed in a neonate at 21 days of age.
- Thirty-seven neonates in the neonatal intensive care unit (NICU) were potentially exposed.
Findings:
- The index patient recovered with anti-tuberculous medication.
- All 36 exposed neonates tested negative for tuberculosis via skin tests.
- 35 exposed infants received isoniazid prophylaxis, with 30 completing at least 3 months of therapy.
Implications:
- This case highlights the importance of early diagnosis of congenital tuberculosis.
- Vigilant follow-up and management of exposures in the NICU are essential to prevent further spread.
Objectives:
We report a case of congenital tuberculosis in a neonatal intensive care unit (NICU) and the management of exposure to other neonates in the hospital. We review the literature regarding congenital tuberculosis and management of exposures in the NICU.
Design:
Case report and a survey of exposures with a 3-month follow-up.
Setting:
Urban hospital.
Patients:
Neonates exposed to a case of congenital tuberculosis.
Interventions:
Exposure to tuberculosis was treated with isoniazid. Purified protein derivative tests were placed at baseline and 3 to 4 months after exposure. Chest radiographs were performed if clinically indicated.
Results:
Congenital tuberculosis was diagnosed in our patient at 21 days of age during a prolonged hospital course. After initiation of anti-tuberculous medications, the patient gradually recovered from his illness. While he was treated in the NICU, there were 37 potentially exposed infants. Of these, 36 were administered tuberculin skin tests (average age, 1.7 months), all of which were read as 0 mm of induration. Of those 37, 35 began prophylaxis with isoniazid, and 30 were able to complete treatment with a minimum of 3 months of isoniazid therapy. Of those 30, two infants received 6 months of therapy. Additionally, 29 of the 37 infants had chest radiographs, none of which showed suspicious infiltrates or adenopathy. Finally, 30 of the 36 infants had repeat tuberculin skin tests at 3 months, all of which were read as 0 mm of induration (average age, 3.7 months).
Conclusion:
Congenital tuberculosis is an uncommon disease t hat requires early diagnosis for successful therapy and vigilant follow-up of potential exposures in the NICU.
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Tuberculosis
